Methadone Clinics in Maryland

Treatment with methadone in Maryland clinics treats opiate addiction using medically assisted treatment that curbs cravings and reduces withdrawal symptoms, dramatically reducing the likelihood of relapse.

Call For Help With Addiction

Talk To Someone Now

  • Find a Clinic Near You
  • Access Help and Resources
  • Get 24-Hour Guidance and Information
410-538-2238
Info iconSponsored

Methadone Clinics in cities of Maryland

Medication Treatment for Opioid Use Disorder in Maryland

Maryland recorded its lowest overdose death total in a decade in 2025, with 1,315 deaths and a 31% drop in fentanyl-related deaths from the year before, according to the state’s Overdose Data Dashboard. Behind that change is a coordinated response that pairs record naloxone distribution with broader access to medication for opioid use disorder, including methadone in Maryland.

This is offered across opioid treatment programs, office-based prescribers, hospitals, jails, and telehealth. The listings on this page show licensed providers across Maryland and the sections below explain how the medications and settings work and how to start care.

The Three Medications and Where to Get Them

Three FDA-approved medications treat opioid use disorder, and Maryland uses all three. Methadone in Maryland is dispensed only through a federally certified opioid treatment program (OTP), often called a methadone clinic, and not at a retail pharmacy.

Buprenorphine, which includes Suboxone (buprenorphine-naloxone) and the monthly extended-release injection Sublocade, can be prescribed in a doctor’s office, also called office-based opioid treatment or OBOT, by any clinician with a standard DEA registration that includes Schedule III authority, and filled at a pharmacy. It is also offered inside OTPs.

Naltrexone, including the monthly Vivitrol injection, is not a controlled substance and can be prescribed by any licensed prescriber; treatment can begin only after a person has been off opioids long enough to avoid precipitated withdrawal, a sudden worsening of withdrawal that can happen if the medication is started too soon.

Telehealth has also widened access to treatment. Buprenorphine can now be started by telehealth, including by phone in many cases, under current federal rules that run through December 31, 2026. Permanent rules are still being finalized, so confirm current options with a provider.

Methadone in Maryland for OUD remains OTP-dispensed, though some OTPs can begin treatment with an audio-visual telehealth visit. Maryland’s Buprenorphine Initiative, run by the state’s Behavioral Health Administration, works to expand buprenorphine access for people 16 and older with opioid use disorder. Which medication and setting fit best is a decision a person makes with a clinician, and you can read more on how methadone and Suboxone compare or how methadone treatment works.

Maryland Medicaid, Naloxone, and State Access Rules

Maryland Medicaid, called HealthChoice and also known locally as Medical Assistance, covers all three FDA-approved medications for opioid use disorder. Substance use treatment is administered through the Public Behavioral Health System, which is carved out of Medicaid managed care and run alongside mental health services by the Behavioral Health Administration.

The 2024 Consolidated Appropriations Act made permanent the federal requirement that state Medicaid programs cover all FDA-approved MOUD, locking in coverage that had previously been time-limited under the SUPPORT Act.

Naloxone access in Maryland is unusually broad. A statewide naloxone standing order, most recently updated August 28, 2025, allows any Maryland-licensed pharmacist to dispense any formulation, including over-the-counter Narcan, to anyone, with no personal prescription and no prior training.

The Maryland Overdose Response Program, administered by the Maryland Department of Health, also authorizes community organizations to distribute naloxone for free and funds local overdose response programs. In 2025, Maryland’s Overdose Response Programs distributed more than 440,000 doses of naloxone and over 272,000 fentanyl test strips, both annual records.

Maryland’s Good Samaritan Law, codified in Health-General Article §13-3101 to §13-3109, protects people who call 911 during an overdose from arrest or prosecution for several drug-related offenses.

Maryland’s Overdose Picture in 2025

Maryland recorded 1,315 overdose deaths in 2025, the state’s lowest annual total in a decade and a 26% decrease from 2024, according to the Maryland Overdose Data Dashboard. Fentanyl-related deaths fell 31% over the same period, from 1,314 in 2024 to 906 in 2025. The 2025 figure represents a 53% decline from Maryland’s historic peak of 2,800 deaths in 2021.

Decreases occurred across all major drug categories and demographic groups, though Maryland Department of Health officials report that non-Hispanic Black men aged 55 and older remained the most affected group, at a rate roughly three times that of white men in the same age range.

State officials credit the broader decline to coordinated work by local health departments, community harm reduction organizations, the Opioid Restitution Fund, and expanded MOUD access. If you are looking for treatment, the listings on this page are the place to start. For background on the condition itself, see what opioid use disorder looks like and how it develops.

How to Start Treatment in Maryland

Starting treatment usually begins with an intake assessment. At an OTP, that means an in-person visit where a clinician confirms the diagnosis, takes a medical history, and starts buprenorphine or methadone in Maryland the same day in most cases.

With an office-based prescriber, a first appointment can often be virtual, and a buprenorphine prescription can be filled at the pharmacy the same day. People starting buprenorphine after recent fentanyl use should plan the timing of the first dose carefully with a clinician to avoid precipitated withdrawal.

Marylanders in crisis can also call or text 988, the Suicide and Crisis Lifeline, or use the state’s 988 treatment locator at search.988.mdinfonet.org to find nearby options. For broader context, see what outpatient opioid treatment involves or, where a higher level of care is appropriate, inpatient or residential treatment.

Treatment During Incarceration, Reentry, and Pregnancy

Maryland has built one of the country’s most comprehensive frameworks for medication treatment during incarceration and reentry. House Bill 116, enacted in 2019 and phased in through 2023, requires all 24 Maryland county jails to offer screening and access to all three FDA-approved medications during incarceration.

In January 2025, the Centers for Medicare and Medicaid Services approved an amendment to Maryland’s HealthChoice 1115 waiver, the Reentry Demonstration, that authorizes Medicaid to cover MOUD and related services for incarcerated people up to 90 days before release, with implementation beginning July 1, 2025. Continuity of medication into the community is the single change most strongly associated with reduced overdose mortality after release.

For pregnant and postpartum Marylanders, the state’s MOM Program provides enhanced case management for Medicaid participants diagnosed with opioid use disorder through the state’s nine managed care organizations.

Buprenorphine and methadone in Maryland are the recommended treatments before, during, and after pregnancy, and the University of Maryland’s MACS for MOMs consultation service supports clinicians providing this care. Families and partners often play a central role in helping a loved one connect to and stay in treatment; see methadone during pregnancy and guidance for families for more.

Frequently Asked Questions

Does Maryland HealthChoice cover all three medications for opioid use disorder?

Yes, Maryland Medicaid covers methadone, buprenorphine (including Suboxone and Sublocade), and naltrexone (including Vivitrol). Coverage is administered through the Public Behavioral Health System. Specifics such as preferred drugs and any prior authorization can vary, so confirm details with the provider you plan to see. For more, see other common questions about methadone treatment.

Can I start buprenorphine through telehealth in Maryland?

In most cases, yes. Federal rules in effect through December 31, 2026 allow any qualified prescriber to begin buprenorphine via telehealth, including by phone in many situations, without a prior in-person visit. A permanent rule for buprenorphine telemedicine took effect December 31, 2025 and runs alongside the temporary extension. Methadone for OUD continues to be dispensed in person through an opioid treatment program.

How do I get naloxone in Maryland?

Any Maryland pharmacy can dispense naloxone, including over-the-counter Narcan, to anyone under the state’s standing order, with no prescription required. Free naloxone is also available from community organizations authorized by Maryland’s Overdose Response Program. Maryland’s Good Samaritan Law protects people who call 911 during an overdose from arrest or prosecution for certain drug-related offenses. For more, see what to do during an opioid overdose.

I am on probation. Will my treatment information be shared?

Federal regulations, including 42 CFR Part 2, give substance use treatment records stronger confidentiality protections than most medical records. A provider can release information to a court or supervision officer only with the patient’s written consent or under narrow legal exceptions. Ask the specific program about its policies before intake.

What if no opioid treatment program is close to me?

Methadone in Maryland for OUD must still be dispensed at an OTP, which means daily or take-home dosing arranged through a certified program. Where the nearest OTP is far away, buprenorphine is often a practical alternative: it can be prescribed in a doctor’s office or by telehealth and filled at a local pharmacy, which removes the daily-visit requirement that methadone treatment usually involves.

Last reviewed and sources

Last reviewed June 2026.

Sources for this page:

This site is not a medical provider and does not provide medical advice, diagnosis, or treatment. The content here is for general informational purposes only; decisions about medication, dose, and care should be made with a licensed clinician.

Calls placed to the helpline number on this site may be answered by a paid advertiser, and the helpline is a referral service. Use of the helpline does not guarantee placement at any particular treatment center, and we do not receive a commission tied to any specific provider in the directory listings on this page.

Gayle Morris

By Gayle Morris

Last Updated: August 27, 2026

Call to Find a Methadone ClinicPhone icon800-780-9619 Info iconSponsored

Where do calls go?

By calling the helpline you agree to the terms of use. We do not receive any commission or fee that is dependent upon which treatment provider a caller chooses. There is no obligation to enter treatment.

Calls to numbers on a specific treatment center listing will be routed to that treatment center. Calls to any general helpline could be forwarded to SAMHSA or a verified treatment provider.

If you wish to connect with non-sponsor centers, you can browse top-rated listings, visit our homepage and browse by state, or visit SAMHSA.